The collaboration enhances A4i’s footprint across health systems, supporting digital innovation in severe mental illness
Among patients with complex behavioural and mental health conditions, 23% face re-hospitalization within 30 days of discharge and 75% stop taking their medications after 18 months. Patient populations with severe mental illness require high patient engagement and support. To address this issue, A4i (App4Independence) offers patients an opportunity to play an active role in their care via a mobile application, promoting greater autonomy. Additionally, A4i’s clinical portal provides their care team with the necessary insights to identify the risk of a relapse, allowing for earlier intervention.
Health Technology Insights: LucyRx, Personify Health Partner to Reduce Employer GLP-1 Costs
With funding support from OBIO’s Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence to adopt and implement the technology, A4i has secured a contract with the Waypoint Centre for Mental Health Care, one of Ontario’s most highly specialized mental health facilities, which offers a range of mental health and addiction services, including specialized care for individuals living with severe mental illness. This partnership is a key milestone for A4i, as it advances commercialization and ROI demonstration in the Canadian healthcare landscape.
In 2024, A4i completed a successful evaluation at the Royal Ottawa Health Centre through OBIO’s Early Adopter Health Network , making the technology available for wider dissemination among network healthcare organizations interested in acquiring A4i. With this partnership, A4i is broadening the adoption of its digital platform in Canada, expanding its commercialization with hospital partners in the province of Ontario.
Health Technology Insights: Kythera Labs Teams Up with Top Analytics Firms for Data Solutions
“By empowering people with the tools to manage their care, while giving clinicians meaningful, real-time insight, we’re solving real-world challenges to improve continuity of care, reducing relapse risk, and supporting recovery beyond the walls of the hospital,” said Amos Adler, Co-Founder of A4i and CEO of MEMOTEXT.
The implementation of the A4i technology at Waypoint will be driven by A4i’s ‘health at home’ initiative. As Waypoint covers a large geographical area, much of which is rural, patients often lack the necessary support within the community. Through the A4i app and portal, individuals with severe mental illness who are either transitioning back to the community from inpatient care or outpatients using community services, will now have another layer of support and connectivity with their care team to help them thrive.
“This milestone partnership between the Waypoint Centre for Mental Health Care and A4i demonstrates the real-world benefits that can be achieved when digital innovation is pursued and critical technologies are deployed within the life sciences sector,” said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. “By investing in organizations like OBIO, our government is committed to strengthening this leading industry, ensuring that we not only build on our past successes, but lay a foundation for competitiveness and economic growth for generations to come. We congratulate Waypoint, A4i, and OBIO on this collaboration and look forward to seeing their combined expertise support patients and care teams across Ontario.”
“We’re thrilled to harness technology to enhance our clients’ recovery, with A4i offering timely resources and peer support to complement our team’s care,” commented Kevin Young, Vice-President Medical Affairs and Chief of Staff at Waypoint.
“The adoption of A4i’s technology at Waypoint is a game changer for individuals with complex behavioural and mental health conditions, providing them with the tools and support they need to be empowered in their healthcare decisions and stay engaged with their healthcare team,” said Dr. Maura Campbell, President and CEO of OBIO. “We are delighted to have facilitated the evaluation and adoption of this technology through our EAHN™ and LSCTC programs.”
Health Technology Insights: Helius Medical Gains Payment Approval for PoNS Device from Aetna Healthcare
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
